Terms: = Pancreatic cancer AND RSPO3, Q9BXY4, THSD2, PWTSR, FLJ14440, CRISTIN1, ENSG00000146374, 84870
5 results:
1. Upregulation of rspo3 via targeted promoter DNA demethylation inhibits the progression of cholangiocarcinoma.
Wu G; Wang D; Xiong F; Liu W; Wang Q; Chen J; Wang B; Chen Y
Clin Epigenetics; 2023 Nov; 15(1):177. PubMed ID: 37932819
[TBL] [Abstract] [Full Text] [Related]
2. The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Reverses Immune Evasion in Wnt Ligand-dependent cancer Models.
Phillips C; Bhamra I; Eagle C; Flanagan E; Armer R; Jones CD; Bingham M; Calcraft P; Edmenson Cook A; Thompson B; Woodcock SA
Cancer Res Commun; 2022 Sep; 2(9):914-928. PubMed ID: 36922934
[TBL] [Abstract] [Full Text] [Related]
3. Cartilage oligomeric matrix protein acts as a molecular biomarker in multiple cancer types.
Guo B; Wang Y; Liu W; Zhang S
Clin Transl Oncol; 2023 Feb; 25(2):535-554. PubMed ID: 36255654
[TBL] [Abstract] [Full Text] [Related]
4. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract] [Full Text] [Related]
5. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
Katoh M; Katoh M
Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
[TBL] [Abstract] [Full Text] [Related]